Target's (NYSE: TGT) troubles have continued thus far in 2025. The retail giant came into the year reeling from market share losses to Walmart, weakness in discretionary categories, and problems with ...

AST SpaceMobile (ASTS +2.86%) wants to connect the world. The company plans to be the leader in using satellite technology to bring broadband directly to cellphone users across the globe. It's been ...

What was good news for a rival was hardly a boon for the Danish pharmaceutical. This concerned a weight-loss drug soon to be submitted for regulatory approval. Investors didn't react happily to this ...

NEW YORK (AP) — Less than a day after gold soared to another record high, prices for the precious metal plunged — marking the biggest sell-off in years. Gold futures in New York closed at a record ...

・Biohaven was seeking approval for its drug Vyglxia in the treatment of Spinocerebellar ataxia. ・The company is in the process of formally requesting a meeting as soon as possible to determine the ...